CYC
CYCLOPHARM FPO [CYC]
Healthcare · ASX Small Cap
$0.8150 -3.6%
Updated 2026-03-02 · Scores refresh every scan
Appeared in 2 consecutive scans→ Score -10First seen: 2026-02-25
Score Breakdown
Technical36
Catalyst52
Sentiment50
Fundamental50
Momentum46
Risk Gate50
Active Signals
Bullish Signals
- RSI approaching oversold
- OBV divergence: distribution detected
- Volatility contracting (breakout setup)
- Critical cash runway (1.5 quarters)
- Low P/S ratio (3.2x)
- Moderate revenue growth (+18%)
- EPS estimates revised upward (+10pts)
- Capital raise activity (1 events)
- CANSLIM I: Institutional ownership (26%)
- ASX200 bullish (+1.5% 5d)
- RBA cutting (+2pts)
Risk Signals
- Price below MAs (downtrend)
- Negative 5-day momentum (-4.1%)
- Below 200-day MA (long-term downtrend)
- Deeply negative margins (-53%)
- Insufficient sentiment data (defaulting to neutral)
- Neutral/mixed sentiment
Recent Catalysts
NONE Update - Proposed issue of securities - CYC
NONE Preliminary Final Report
NONE Technegas US Footprint Expanding Across Four Regions
LOW Chairman David Heaney to Retire at 2026 AGM
Recent ASX Announcements
| 2026-02-25 | Update - Proposed issue of securities - CYC |
| 2026-02-25 | Preliminary Final Report PRICE SENSITIVE |
| 2026-02-25 | Chairman David Heaney to Retire at 2026 AGM |
| 2026-02-19 | Technegas US Footprint Expanding Across Four Regions PRICE SENSITIVE |
| 2026-02-18 | Technegas Approved at the US National Institutes of Health PRICE SENSITIVE |
Key Metrics
$101.9M
Market Cap
103K
Avg Volume
0.6x
Vol Ratio
$0.56 — $1.55
52-Week Range
0.0%
Short Interest
N/A
Cash Runway
-49.3%
ROE
-53.3%
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: 0% |
| A | Annual Earnings | fail | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | neutral | Float: 50% |
| L | Leader vs Laggard | laggard | RS: -2 |
| I | Institutional Sponsorship | pass | Inst: 26% |
| M | Market Direction | pass | Bullish |
Sector: Healthcare
Ranked #112 of 119 · Sector avg: 51
View all Healthcare signals →